|
|
肿瘤相关巨噬细胞在胃癌中的研究进展
|
Abstract:
肿瘤相关巨噬细胞在不同因子的作用下可以分化为经典活化型和交替活化型两种表型，两种表型对胃癌细胞的发生、发展发挥相反的作用，其中，M2型能够分泌多种趋化因子，抑制炎性反应的发生，促进血管和淋巴管形成。胃癌是常见的恶性消化道肿瘤，患者整体生存率还较低，因此寻找特异性的能够预测预后的因素，开发新的作用靶点迫在眉睫。鉴于此本文就肿瘤相关巨噬细胞在胃癌中的有关研究进行分析、综述，以期为改善胃癌患者预后，研发新型靶向药物提供新视角。
Tumor-associated macrophages can differentiate into two phenotypes, classical activation and al-ternating activation under the action of different factors, and the two phenotypes play opposite roles on the occurrence and development of gastric cancer cells, among which M2 can secrete a va-riety of chemokines, inhibit the occurrence of inflammatory reactions, and promote the formation of blood vessels and lymphatic vessels. Gastric cancer is a common malignant digestive tract tumor, and the overall survival rate of patients is still low, so it is urgent to find specific factors that can predict prognosis and develop new targets. In view of this, this paper analyzes and reviews the rel-evant research of tumor-associated macrophages in gastric cancer, in order to provide a new per-spective for improving the prognosis of gastric cancer patients and developing new targeted drugs.
| [1] | Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249.
https://doi.org/10.3322/caac.21660 |
| [2] | 王静, 丁鹏鹏, 王亚丹, 崔建芳, 王沧海, 刘红. T1M1期胃癌患者临床病理特征及预后生存分析[J]. 胃肠病学和肝病学杂志, 2021, 30(10): 1107-1111. |
| [3] | Bejarano, L., Jordāo, M.J.C. and Joyce, J.A. (2021) Therapeutic Targeting of the Tumor Microenvironment. Cancer Discovery, 11, 933-959. https://doi.org/10.1158/2159-8290.CD-20-1808 |
| [4] | Mantovani, A., Marchesi, F., Jaillon, S., et al. (2021) Tu-mor-Associated Myeloid Cells: Diversity and Therapeutic Targeting. Cellular & Molecular Immunology, 18, 566. https://doi.org/10.1038/s41423-020-00613-4 |
| [5] | Yang, S., Liu, Q. and Liao, Q. (2020) Tumor-Associated Mac-rophages in Pancreatic Ductal Adenocarcinoma: Origin, Polarization, Function, and Reprogramming. Frontiers in Cell and Developmental Biology, 8, Article ID: 607209.
https://doi.org/10.3389/fcell.2020.607209 |
| [6] | Ruytinx, P., Proost, P., Van Damme, J., et al. (2018) Chemo-kine-Induced Macrophage Polarization in Inflammatory Conditions. Frontiers in Immunology, 9, 1930. https://doi.org/10.3389/fimmu.2018.01930 |
| [7] | Zeng, D., Li, M., Zhou, R., et al. (2019) Tumor Microenvironment Characterization in Gastric Cancer Identifies Prognostic and Immunotherapeutically Relevant Gene Signatures. Cancer Immunology Research, 7, 737-750.
https://doi.org/10.1158/2326-6066.CIR-18-0436 |
| [8] | Hardbower, D.M., Asim, M., Murray-Stewart, T., et al. (2016) Arginase 2 Deletion Leads to Enhanced M1 Macrophage Activation and Upregulated Polyamine Metabolism in Response to Helicobacter pylori Infection. Amino Acids, 48, 2375-2388. https://doi.org/10.1007/s00726-016-2231-2 |
| [9] | Wang, Z., Yang, Y., Cui, Y., et al. (2020) Tumor-Associated Macrophages Regulate Gastric Cancer Cell Invasion and Metastasis through TGFβ2/NF-κB /Kindlin-2 Axis. Chinese Journal of Cancer Research, 32, 72-88.
https://doi.org/10.21147/j.issn.1000-9604.2020.01.09 |
| [10] | Ostuni, R., Kratochvill, F., Murray, P.J., et al. (2015) Macrophages and Cancer: From Mechanisms to Therapeutic Implications. Trends in Immunology, 36, 229-239. https://doi.org/10.1016/j.it.2015.02.004 |
| [11] | Achkovad, M. (2016) Role of the Colony-Stimulating Factor (CSF)/CSF-1 Receptor Axis in Cancer. Biochemical Society Transactions, 44, 333-341. https://doi.org/10.1042/BST20150245 |
| [12] | Ma, F., Zhang, B., Ji, S., et al. (2019) Hypoxic Macrophage-Derived VEGF Promotes Proliferation and Invasion of Gastric Cancer Cells. Digestive Diseases and Sciences, 64, 3154-3163. https://doi.org/10.1007/s10620-019-05656-w |
| [13] | Liu, D., Wang, N., Sun, Y., et al. (2018) Expression of VEGF with Tumor Incidence, Metastasis and Prongnosis in Human Gastric Carcinoma. Cancer Biomarkers, 22, 693-700. https://doi.org/10.3233/CBM-171163 |
| [14] | Zhu, J., Zhi, Q., Zhou, B.P., et al. (2016) The Role of Tumor Associat-ed Macrophages in the Tumor Microenvironment: Mechanism and Functions. Anti-Cancer Agents in Medicinal Chemis-try, 16, 1133-1141.
https://doi.org/10.2174/1871520616666160520112622 |
| [15] | Ma, Y.Y., He, X.J., Wang, H.J., et al. (2011) Interac-tion of Coagulation Factors and Tumor-Associated Macrophages Mediates Migration and Invasion of Gastric Cancer. Cancer Science, 102, 336-342.
https://doi.org/10.1111/j.1349-7006.2010.01795.x |
| [16] | Shen, Z.L., Yan, Y.C., Ye, C., et al. (2016) The Effect of Vasohibin-1 Expression and Tumor-Associated Macrophages on the Angiogenesis in Vitro and in Vivo. Tumor Biology, 37, 7267-7276.
https://doi.org/10.1007/s13277-015-4595-4 |
| [17] | 邱森, 孙淼淼, 陈奎生. 肿瘤相关巨噬细胞对肿瘤血管生成影响的研究进展[J]. 细胞与分子免疫学杂志, 2019, 35(5): 469-472. |
| [18] | Liu, J.Y., Yang, X.J., Geng, X.F., et al. (2016) Prognostic Significance of Tumor-Associated Macrophages Density in Gastric Cancer: A Systemic Review and Meta-Analysis. Minerva Medica, 107, 314-321. |
| [19] | Tauchi, Y., Tanaka, H., Kumamoto, K., et al. (2016) Tu-mor-Associated Macrophages Induce Capillary Morphogenesis of Lymphatic Endothelial Cells Derived from Human Gastric Cancer. Cancer Science, 107, 1101-1109.
https://doi.org/10.1111/cas.12977 |
| [20] | Chen, H., Guan, R., Lei, Y., et al. (2015) Lymphangiogenesis in Gastric Cancer Regulated through Akt/mTOR-VEGF- C/VEGF-D Axis. BMC Cancer, 15, 103. https://doi.org/10.1186/s12885-015-1109-0 |
| [21] | Pathria, P., Louis, T.L. and Varner, J.A. (2019) Targeting Tu-mor-Associated Macrophages in Cancer. Trends in Immunology, 40, 310-327. https://doi.org/10.1016/j.it.2019.02.003 |
| [22] | Liu, Y., Ye, Y. and Zhu, X. (2019) MMP-9 Secreted by Tumor As-sociated Macrophages Promoted Gastric Cancer Metastasis through a PI3K/AKT/Snail Pathway. Biomedicine & Phar-macotherapy, 117, Article ID: 109096.
https://doi.org/10.1016/j.biopha.2019.109096 |
| [23] | Eissmann, M.F., Dijkstra, C., Jarnicki, A., et al. (2019) IL-33-Mediated Mast Cell Activation Promotes Gastric Cancer through Macrophage Mobilization. Nature Communica-tions, 10, 2735. https://doi.org/10.1038/s41467-019-10676-1 |
| [24] | Liu, X., Xu, D., Huang, C., et al. (2019) Regu-latory T Cells and M2 Macrophages Present Diverse Prognostic Value in Gastric Cancer Patients with Different Clinico-pathologic Characteristics and Chemotherapy Strategies. Journal of Translational Medicine, 17, 192. https://doi.org/10.1186/s12967-019-1929-9 |
| [25] | Huang, Y.K., Wang, M., Sun, Y., et al. (2019) Macrophage Spa-tial Heterogeneity in Gastric Cancer Defined by Multiplex Immunohistochemistry. Nature Communications, 10, 3928. https://doi.org/10.1038/s41467-019-11788-4 |
| [26] | Binenbaum, Y., Fridman, E., Yaari, Z., et al. (2018) Transfer of miRNA in Macrophage-Derived Exosomes Induces Drug Resistance in Pancreatic Adenocarcinoma. Cancer Research, 78, 5287-5299.
https://doi.org/10.1158/0008-5472.CAN-18-0124 |
| [27] | Zhuang, H., Dai, X., Zhang, X., et al. (2020) Sophoridine Suppresses Macrophage-Mediated Immunosuppression through TLR4/IRF3 Pathway and Subsequently Upregulates CD8+ T Cytotoxic Function against Gastric Cancer. Biomedicine & Pharmacotherapy, 121, Article ID: 109636. https://doi.org/10.1016/j.biopha.2019.109636 |
| [28] | Wang, X., Jiao, X., Meng, Y., et al. (2018) Methionine Enkephalin (MENK) Inhibits Human Gastric Cancer through Regulating Tumor Associated Macrophages (TAMs) and PI3K/AKT/mTOR Signaling Pathway inside Cancer Cells. International Immunopharmacology, 65, 312-322. https://doi.org/10.1016/j.intimp.2018.10.023 |
| [29] | Yamaguchi, T., Fushida, S., Yamamoto, Y., et al. (2017) Low-Dose Paclitaxel Suppresses the Induction of M2 Macrophages in Gastric Cancer. Oncology Reports, 37, 3341-3350. https://doi.org/10.3892/or.2017.5586 |
| [30] | Cassier, P.A., Italiano, A., Gomez-Roca, C.A., et al. (2015) CSF1R In-hibition with Emactuzumab in Locally Advanced Diffuse-Type Tenosynovial Giant Cell Tumours of the Soft Tissue: A Dose-Escalation and Dose-Expansion Phase 1 Study. The Lancet Oncology, 16, 949-956. https://doi.org/10.1016/S1470-2045(15)00132-1 |
| [31] | Aldinucci, D. and Casagrande, N. (2018) Inhibition of the CCL5/CCR5 Axis against the Progression of Gastric Cancer. International Journal of Molecular Sciences, 19, 1477. https://doi.org/10.3390/ijms19051477 |
| [32] | Zang, X., Zhang, X., Hu, H., et al. (2019) Targeted Delivery of Zoledronate to Tumor-Associated Macrophages for Cancer Immunotherapy. Molecular Pharmaceutics, 16, 2249-2258.
https://doi.org/10.1021/acs.molpharmaceut.9b00261 |
